Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China.
Institut Curie, Paris, France.
J Thorac Oncol. 2024 Jan;19(1):52-70. doi: 10.1016/j.jtho.2023.09.1447. Epub 2023 Sep 27.
Stage classification is an important underpinning of management in patients with cancer and rests on a combination of three components-T for tumor extent, N for nodal involvement, and M for distant metastases. This article details the revision of the N and the M components of thymic epithelial tumors for the ninth edition of the TNM classification of malignant tumors proposed by the Thymic Domain of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee.
The N and M components of the eighth edition staging system were verified by a large international collaborative data source through a data-driven analysis. A total of 9147 cases were included for analysis, including 7662 thymomas, 1345 thymic carcinomas, and 140 neuroendocrine thymic tumors.
Lymph node involvement rates were 1.5% in thymomas and 17.6% and 27.7% in thymic carcinomas and neuroendocrine thymic tumors, respectively. Rates of lymph node metastasis were increasingly higher in tumors with higher T stage and higher-grade histologic type. Survival analysis validated the differences in the N and M categories proposed in the eighth edition staging system. Good discrimination in overall survival was detected among pathologic (p)N and pM categories in patients with thymoma and thymic carcinoma.
No changes are proposed from the eighth edition for the N and M components. The proposed stage classification will provide a useful tool for management of the disease among the global thymic community.
分期分类是癌症患者管理的重要基础,它建立在三个组成部分的基础上——T 代表肿瘤范围,N 代表淋巴结受累,M 代表远处转移。本文详细介绍了国际肺癌研究协会胸腺肿瘤分期和预后因素委员会提出的第 9 版 TNM 恶性肿瘤分类中 N 和 M 成分的修订。
通过数据驱动分析,利用大型国际协作数据源验证了第 8 版分期系统的 N 和 M 成分。共纳入 9147 例患者进行分析,包括 7662 例胸腺瘤、1345 例胸腺癌和 140 例神经内分泌胸腺肿瘤。
胸腺瘤的淋巴结受累率为 1.5%,胸腺癌和神经内分泌胸腺肿瘤的淋巴结受累率分别为 17.6%和 27.7%。淋巴结转移率在 T 分期较高和组织学分级较高的肿瘤中逐渐升高。生存分析验证了第 8 版分期系统中 N 和 M 类别的差异。在胸腺瘤和胸腺癌患者中,病理(p)N 和 pM 类别的总体生存率存在良好的区分度。
第 8 版的 N 和 M 成分没有变化。拟议的分期分类将为全球胸腺肿瘤领域的疾病管理提供有用的工具。